Literature DB >> 29030249

Sex as a biological variable: Drug use and abuse.

Anthony L Riley1, Briana J Hempel2, Matthew M Clasen2.   

Abstract

The study of sex as a biological variable is a necessary emphasis across a wide array of endpoints, including basic neuroscience, medicine, mental health, physiology and behavior. The present review summarizes work from clinical and preclinical populations on sex differences in drug use and abuse, ranging from initiation to escalation/dysregulation and from drug cessation/abstinence to relapse. These differences are analyzed in the context of the addiction cycle conceptualization of Koob and his colleagues and address patterns of drug use (binge/intoxication), motivation underlying its use (withdrawal/negative affect) and likelihood and causes of craving and relapse of drug taking (preoccupation/anticipation). Following this overview, an assessment of the basis for the reported sex differences is discussed in the context of the affective (rewarding and aversive) properties of drugs of abuse and how such properties and their balance vary with sex and contribute to drug intake. Finally, the interaction of sex with several experiential (drug history) and subject (age) factors and how these interactions affect reward and aversion are discussed to highlight the importance of understanding such interactions in predicting drug use and abuse. We note that sex as a biological variable remains one of critical evaluation and that such investigations of sex differences in drug use and abuse continue and be expanded to assess all facets of their mediation, including these affective properties, how their balance may be impacted by the multiple conditions under which drugs are taken and how this overall balance affects drug use and addiction vulnerability.
Copyright © 2017 Elsevier Inc. All rights reserved.

Keywords:  Addiction cycle; Aversion; Clinical and preclinical populations; Drug use and abuse; Reward; Sex differences

Mesh:

Year:  2017        PMID: 29030249     DOI: 10.1016/j.physbeh.2017.10.005

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  19 in total

1.  Within-animal comparisons of novelty and cocaine neuronal ensemble overlap in the nucleus accumbens and prefrontal cortex.

Authors:  Natalie N Nawarawong; Christopher M Olsen
Journal:  Behav Brain Res       Date:  2019-10-12       Impact factor: 3.332

2.  Sex differences in α-pyrrolidinopentiophenone (α-PVP)-induced taste avoidance, place preference, hyperthermia and locomotor activity in rats.

Authors:  Katharine H Nelson; Hayley N Manke; Aikerim Imanalieva; Kenner C Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2019-08-21       Impact factor: 3.533

3.  Filling the Regulatory Gap: Potential Role of Institutional Review Boards in Promoting Consideration of Sex as a Biological Variable.

Authors:  Korrina A Duffy; Tracy A Ziolek; C Neill Epperson
Journal:  J Womens Health (Larchmt)       Date:  2020-04-08       Impact factor: 2.681

4.  Count me in: using a patient portal to minimize implicit bias in clinical research recruitment.

Authors:  Vaishnavi Kannan; Kathleen E Wilkinson; Mereeja Varghese; Sarah Lynch-Medick; Duwayne L Willett; Teresa A Bosler; Ling Chu; Samantha I Gates; M E Blair Holbein; Mallory M Willett; Sharon C Reimold; Robert D Toto
Journal:  J Am Med Inform Assoc       Date:  2019-08-01       Impact factor: 4.497

Review 5.  Epigenetic pharmacotherapy for substance use disorder.

Authors:  Gregory C Sartor
Journal:  Biochem Pharmacol       Date:  2019-07-12       Impact factor: 5.858

Review 6.  Factors modulating the incubation of drug and non-drug craving and their clinical implications.

Authors:  Marco Venniro; Ingrid Reverte; Leslie A Ramsey; Kimberly M Papastrat; Ginevra D'Ottavio; Michele Stanislaw Milella; Xuan Li; Jeffrey W Grimm; Daniele Caprioli
Journal:  Neurosci Biobehav Rev       Date:  2021-09-28       Impact factor: 8.989

Review 7.  Role of Exogenous Progesterone in the Treatment of Men and Women with Substance Use Disorders: A Narrative Review.

Authors:  MacKenzie R Peltier; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2018-05       Impact factor: 5.749

Review 8.  Nicotine and alcohol: the role of midbrain dopaminergic neurons in drug reinforcement.

Authors:  Carole Morel; Sarah Montgomery; Ming-Hu Han
Journal:  Eur J Neurosci       Date:  2018-10-15       Impact factor: 3.386

Review 9.  Therapeutic Potential of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Substance Use Disorders: A Synthesis of Preclinical and Human Evidence.

Authors:  Justin Matheson; Bernard Le Foll
Journal:  Cells       Date:  2020-05-12       Impact factor: 6.600

10.  Income generation and the patterning of substance use: A gender-based analysis.

Authors:  Kaitlyn Jaffe; Ekaterina Nosova; Lisa Maher; Kanna Hayashi; M-J Milloy; Lindsey Richardson
Journal:  Drug Alcohol Depend       Date:  2021-06-24       Impact factor: 4.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.